ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Codiak BioSciences Inc

Codiak BioSciences Inc (CDAK)

0.057
0.00
( 0.00% )
Updated: 19:00:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.057
Bid
0.0447
Ask
0.0448
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.057
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CDAK Latest News

Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 Process

CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics...

Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics...

Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting

– exoASO-STAT6 demonstrated durable pharmacokinetic/pharmacodynamic profile in preclinical models; biomarkers with clinical translational potential identified, providing a rationale for selecting...

Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress

– Patient enrollment continuing in Phase 1 clinical trial of exoASO™-STAT6 in patients with advanced hepatocellular carcinoma; preliminary data anticipated during 1H 2023 – – Presented preclinical...

Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related Sarbecoviruses

– Data support advancement of Codiak’s engineered exosome bivalent vaccine candidate toward IND-enabling studies – CAMBRIDGE, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc...

Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting Macrophages

– Data to be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting – CAMBRIDGE, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a...

Codiak Announces Pricing of $20 Million Public Offering of Common Stock and Warrants

CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a clinical-stage biopharmaceutical company pioneering the development of exosome-based...

Codiak Announces Proposed Public Offering of Common Stock and Warrants

CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a clinical-stage biopharmaceutical company pioneering the development of exosome-based...

Codiak BioSciences Announces Program Reprioritization and Corporate Restructuring

– Enrollment continues in Phase 1 clinical trial of IV-administered exoASO™-STAT6 in patients with advanced hepatocellular carcinoma –                   – Prioritizing vaccine program funded by...

Codiak BioSciences Reports Second Quarter 2022 Financial Results and Operational Progress

– Reported platform-validating initial data from Phase 1 studies of exoSTING™ and exoIL-12™; plans to initiate Phase 2 studies for both programs in 1H 2023 – – Initiated patient dosing in Phase 1...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CDAK - Frequently Asked Questions (FAQ)

What is the current Codiak BioSciences share price?
The current share price of Codiak BioSciences is $ 0.057
What is the 1 year trading range for Codiak BioSciences share price?
Codiak BioSciences has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SLXNSilexion Therapeutics Corporation
$ 1.2174
(109.90%)
175.96M
RNAZTransCode Therapeutics Inc
$ 12.00
(75.70%)
18.01M
YIBOPlanet Image International Ltd
$ 4.96
(61.04%)
48.81M
BACKIMAC Holdings Inc
$ 1.169
(41.01%)
52.81M
RFACRF Acquisition Corporation
$ 6.91
(38.20%)
61.05k
LPTXLeap Therapeutics Inc
$ 0.6395
(-71.58%)
8.11M
STSSSharps Technology Inc
$ 0.4361
(-70.13%)
11.78M
SABSSAB Biotherapeutics Inc
$ 2.205
(-49.43%)
940.79k
MGOLMGO Global Inc
$ 0.1751
(-38.13%)
14.79M
INKTMiNK Therapeutics Inc
$ 6.4159
(-27.41%)
67.48k
NVDANVIDIA Corporation
$ 121.48
(2.58%)
249.48M
HEPAHepion Pharmaceuticals Inc
$ 0.2232
(35.27%)
233.22M
SLXNSilexion Therapeutics Corporation
$ 1.2136
(109.24%)
175.96M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.5085
(23.39%)
135.5M
TRIBTrinity Biotech PLC
$ 1.0496
(38.11%)
98.92M

Discussion

View Full Feed
ignatiusrielly35 ignatiusrielly35 1 minute ago
Must be the charlatan's twin brother. 
XRPUSD
kennyt 335 kennyt 335 2 minutes ago
Agreed kayak it is a shame LG wouldn’t wait to sell if he actually did! ELTP$$$$$$$
ELTP
fink fink 2 minutes ago
23degrees in Atlanta. Had to unwinterize an investment piece of property for a home inspection, found two busted pipes. Try and find a plumber in Atlanta after a good frenzy.

Like trying to get FINRA to do a symbol name change.
IGPK
abrooklyn abrooklyn 2 minutes ago
https://x.com/CorePassCC/status/1884255437911945668
ARAT
ignatiusrielly35 ignatiusrielly35 2 minutes ago
The information about an open put position should not scare anybody because it is meaningless. There are more calls at the $3 strike price than puts. And there are far more calls at all strikes for the Jan '26 options than there are puts. Nice try, though. 
AVXL
ProfitScout ProfitScout 2 minutes ago
$IQST - iQSTEL Releases 2025 Shareholder Letter Highlighting Strategic Growth, M&A 2025 Campaign, and Vision for a $1 Billion Corporation Future

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- iQSTEL Inc. (OTCQX: IQST), a leading innovator in the technology and telecommunications sectors, is
IQST
chumppunk chumppunk 2 minutes ago
D0lph- Glad your back with TA here. Always follow your comments, "what's possible", either way.
Chump
CYDY
NoMoDo NoMoDo 2 minutes ago
Thank you for posting this. Haven't had much time lately to keep an eye on everything.
HMBL
glenn1919 glenn1919 3 minutes ago
TNXP.....NVNI......ZKIN......CMPX........https://stockcharts.com/h-sc/ui?s=NVNI&p=D&yr=0&mn=2&dy=12&id=p84071410134
CMPX NVNI TNXP
 stock king 1 stock king 1 3 minutes ago
Jim Bo were the $500,000.00 did you spend it . Where the fake sales peoples did you fire them …
VXIT
Almosthere Almosthere 3 minutes ago
Sounds to me like you are going to ChatGPT for advice?
LQMT
jxyzobrien jxyzobrien 3 minutes ago
just market profile fundamentals
discovering its a selling climax allows you to buy and hold an established low with confindence
pauljon4 pauljon4 3 minutes ago
From what I can tell is that an acting director can place your company into conservatorship, and a confirmed director can make it more difficult to exit conservatorship.
FNMA
jour_trader jour_trader 3 minutes ago
Good post. I think for your 3rd point you intended to say they launched into billion dollar markets. They haven't launched billions of product. We simply don't have the quota or resources to do that out of the gate. Will these be many multi-million dollar opportunities? Absolutely, just not billions
ELTP
TimeIsFading TimeIsFading 3 minutes ago
Here are the API's available. Plus I'm sure you could ask them for access to their complete list or I could probably get you that.
https://www.nutrivanceglobal.com/api https://www.nutrivanceglobal.com/api
https://i.imgur.com/i6TGXJ5.png
API
glenn1919 glenn1919 3 minutes ago
FUBO......PRFX......STIM.......SLXN.......................https://stockcharts.com/h-sc/ui?s=SLXN&p=D&yr=0&mn=2&dy=12&id=p84071410134
FUBO PRFX SLXN
rickstereo3333 rickstereo3333 3 minutes ago
Are you honestly attempting to draw a comparison between a MedTech company that is potentially on the cusp of revolutionizing Cancer treatment (Vivos) with a former Oil and Gasco that filed for Chapter 7, and now operates as a Trucking company that ferries Flowers and Produce!?!?!

Als
RDGL
BadaBingPebble BadaBingPebble 3 minutes ago
The volume has been next to nothing, so I do not think people are trying to buy at all. Kudos for the positivity, but it continues to show no signs of life so not sure how it would ever run.
TONR
Mr. Dragon Mr. Dragon 4 minutes ago
Pinocchio was honest in comparison.
DPLS
Rader1977 Rader1977 4 minutes ago
I've watched all of the presentations going back about 4-5 years since I came into this stock and I can honestly say I came away from this most recent conference video very optimistic.

Jim Sims' gave the impression he wanted to reveal a big announcement but he refrained. His tone and
NB
JSmith5 JSmith5 4 minutes ago
What is the difference between an acting and full director ?

See FOFreddie Post #815075 for really good explanation.

Nats short answer: "$20K/yr"

Nats
FNMA
georgejjl georgejjl 4 minutes ago
Within the next 2 days AVXL will issue a press release regarding a NEW Parkinson's disease potentially pivotal trial.

Good luck and GOD bless,
AVXL
crescentmotor crescentmotor 4 minutes ago
No way of knowing if that's a short bet or a long hedge.

Correct
AVXL
FOFreddie FOFreddie 4 minutes ago
Hope you are right - Dems are trying to slow everything down. Maybe a recess appointment will speed things up.
FNMA